Trenton, December 1, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning today’s announced agreement between the United States and the United Kingdom on pharmaceutical prices.
“For generations, America has led the world in discovering new treatments and cures for humanity’s most dreaded diseases, but for far too long other countries haven’t paid their fair share of those life-saving medical advances. Today’s announcement brings American patients one step closer to a more equitable system where other countries help shoulder the extraordinary costs and risks of finding these new treatments and cures, many of which are discovered and manufactured right here in New Jersey.”